series-c-plus
Stage
1
Investors
About
Phaxiam Therapeutics is a biopharmaceutical company developing innovative treatments for severe and resistant bacterial infections using bacteriophage-based therapies.
Explore Phaxiam's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.